Randomized phase 2, first line, of 5-FU, folinic acid, gemcitabine (FFG) versus FOLFOX-4 in patients (pts) with metastatic colorectal carcinoma (mCRC). Work in progress
Author Department
Medicine
Document Type
Presentations, Research
Publication Date
6-1-2005
Recommended Citation
Madajewicz S, Chen WT, Waterhouse D, Higby D, Leichman C, Ritch P, Khan M, Malik S, Hentschel P, Nicol S W. C. Mertens, L. J. Cassells, D. E. Brown. Randomized phase 2, first line, of 5-FU, folinic acid, gemcitabine (FFG) versus FOLFOX-4 in patients (pts) with metastatic colorectal carcinoma (mCRC). Work in progress. American Society of Clinical Oncology Annual Meeting. Orlando, FL. May 13-May 17, 2005.
COinS